DNA damage leads to the incorporation of defects and aberrations in the genome that often result in functional mutations. When these mutations occur in genes coding for vital proteins and/or enzymes, it leads to the development of genetic diseases. However, our biological system is equipped with a robust repair mechanism capable of correcting damaged DNA sequences. PARP inhibitors and other similar therapeutics are designed to augment the body's innate DNA repair mechanism and aid in the treatment of diseases associated with genetic aberrations.
This report contains market size and forecasts of DNA Repair Drugs in global, including the following market information:
Global DNA Repair Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global DNA Repair Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five DNA Repair Drugs companies in 2021 (%)
The global DNA Repair Drugs market was valued at 610.8 million in 2021 and is projected to reach US$ 1901.1 million by 2028, at a CAGR of 17.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
PARP Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of DNA Repair Drugs include 4SC AG, ARCAGY/ GINECO GROUP, Bristol Myers Squibb, British Columbia Cancer Agency, Cambridge University Hospitals NHS Foundation Trust, Genentech, Georgetown University, German Breast Group and GlaxoSmithKline, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the DNA Repair Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global DNA Repair Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global DNA Repair Drugs Market Segment Percentages, by Type, 2021 (%)
- PARP Inhibitors
- Other
Global DNA Repair Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global DNA Repair Drugs Market Segment Percentages, by Application, 2021 (%)
- Oncological
- Stroke
Global DNA Repair Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global DNA Repair Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies DNA Repair Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies DNA Repair Drugs revenues share in global market, 2021 (%)
Key companies DNA Repair Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies DNA Repair Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- 4SC AG
- ARCAGY/ GINECO GROUP
- Bristol Myers Squibb
- British Columbia Cancer Agency
- Cambridge University Hospitals NHS Foundation Trust
- Genentech
- Georgetown University
- German Breast Group
- GlaxoSmithKline
- Jiangsu Hengrui Medicine
- Johnson & Johnson
- Jonsson Comprehensive Cancer Center
- Karyopharm Therapeutics
- KuDOS Pharmaceuticals
- National Health Service
- National Institutes of Health
- Tesaro
DNA Repair Drugs Market - Global Outlook and Forecast 2022-2028
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 DNA Repair Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global DNA Repair Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global DNA Repair Drugs Overall Market Size
2.1 Global DNA Repair Drugs Market Size: 2021 VS 2028
2.2 Global DNA Repair Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global DNA Repair Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top DNA Repair Drugs Players in Global Market
3.2 Top Global DNA Repair Drugs Companies Ranked by Revenue
3.3 Global DNA Repair Drugs Revenue by Companies
3.4 Global DNA Repair Drugs Sales by Companies
3.5 Global DNA Repair Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 DNA Repair Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers DNA Repair Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 DNA Repair Drugs Players in Global Market
3.8.1 List of Global Tier 1 DNA Repair Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 DNA Repair Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global DNA Repair Drugs Market Size Markets, 2021 & 2028
4.1.2 PARP Inhibitors
4.1.3 Other
4.2 By Type - Global DNA Repair Drugs Revenue & Forecasts
4.2.1 By Type - Global DNA Repair Drugs Revenue, 2017-2022
4.2.2 By Type - Global DNA Repair Drugs Revenue, 2023-2028
4.2.3 By Type - Global DNA Repair Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global DNA Repair Drugs Sales & Forecasts
4.3.1 By Type - Global DNA Repair Drugs Sales, 2017-2022
4.3.2 By Type - Global DNA Repair Drugs Sales, 2023-2028
4.3.3 By Type - Global DNA Repair Drugs Sales Market Share, 2017-2028
4.4 By Type - Global DNA Repair Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global DNA Repair Drugs Market Size, 2021 & 2028
5.1.2 Oncological
5.1.3 Stroke
5.2 By Application - Global DNA Repair Drugs Revenue & Forecasts
5.2.1 By Application - Global DNA Repair Drugs Revenue, 2017-2022
5.2.2 By Application - Global DNA Repair Drugs Revenue, 2023-2028
5.2.3 By Application - Global DNA Repair Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global DNA Repair Drugs Sales & Forecasts
5.3.1 By Application - Global DNA Repair Drugs Sales, 2017-2022
5.3.2 By Application - Global DNA Repair Drugs Sales, 2023-2028
5.3.3 By Application - Global DNA Repair Drugs Sales Market Share, 2017-2028
5.4 By Application - Global DNA Repair Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global DNA Repair Drugs Market Size, 2021 & 2028
6.2 By Region - Global DNA Repair Drugs Revenue & Forecasts
6.2.1 By Region - Global DNA Repair Drugs Revenue, 2017-2022
6.2.2 By Region - Global DNA Repair Drugs Revenue, 2023-2028
6.2.3 By Region - Global DNA Repair Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global DNA Repair Drugs Sales & Forecasts
6.3.1 By Region - Global DNA Repair Drugs Sales, 2017-2022
6.3.2 By Region - Global DNA Repair Drugs Sales, 2023-2028
6.3.3 By Region - Global DNA Repair Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America DNA Repair Drugs Revenue, 2017-2028
6.4.2 By Country - North America DNA Repair Drugs Sales, 2017-2028
6.4.3 US DNA Repair Drugs Market Size, 2017-2028
6.4.4 Canada DNA Repair Drugs Market Size, 2017-2028
6.4.5 Mexico DNA Repair Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe DNA Repair Drugs Revenue, 2017-2028
6.5.2 By Country - Europe DNA Repair Drugs Sales, 2017-2028
6.5.3 Germany DNA Repair Drugs Market Size, 2017-2028
6.5.4 France DNA Repair Drugs Market Size, 2017-2028
6.5.5 U.K. DNA Repair Drugs Market Size, 2017-2028
6.5.6 Italy DNA Repair Drugs Market Size, 2017-2028
6.5.7 Russia DNA Repair Drugs Market Size, 2017-2028
6.5.8 Nordic Countries DNA Repair Drugs Market Size, 2017-2028
6.5.9 Benelux DNA Repair Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia DNA Repair Drugs Revenue, 2017-2028
6.6.2 By Region - Asia DNA Repair Drugs Sales, 2017-2028
6.6.3 China DNA Repair Drugs Market Size, 2017-2028
6.6.4 Japan DNA Repair Drugs Market Size, 2017-2028
6.6.5 South Korea DNA Repair Drugs Market Size, 2017-2028
6.6.6 Southeast Asia DNA Repair Drugs Market Size, 2017-2028
6.6.7 India DNA Repair Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America DNA Repair Drugs Revenue, 2017-2028
6.7.2 By Country - South America DNA Repair Drugs Sales, 2017-2028
6.7.3 Brazil DNA Repair Drugs Market Size, 2017-2028
6.7.4 Argentina DNA Repair Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa DNA Repair Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa DNA Repair Drugs Sales, 2017-2028
6.8.3 Turkey DNA Repair Drugs Market Size, 2017-2028
6.8.4 Israel DNA Repair Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia DNA Repair Drugs Market Size, 2017-2028
6.8.6 UAE DNA Repair Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 4SC AG
7.1.1 4SC AG Corporate Summary
7.1.2 4SC AG Business Overview
7.1.3 4SC AG DNA Repair Drugs Major Product Offerings
7.1.4 4SC AG DNA Repair Drugs Sales and Revenue in Global (2017-2022)
7.1.5 4SC AG Key News
7.2 ARCAGY/ GINECO GROUP
7.2.1 ARCAGY/ GINECO GROUP Corporate Summary
7.2.2 ARCAGY/ GINECO GROUP Business Overview
7.2.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Major Product Offerings
7.2.4 ARCAGY/ GINECO GROUP DNA Repair Drugs Sales and Revenue in Global (2017-2022)
7.2.5 ARCAGY/ GINECO GROUP Key News
7.3 Bristol Myers Squibb
7.3.1 Bristol Myers Squibb Corporate Summary
7.3.2 Bristol Myers Squibb Business Overview
7.3.3 Bristol Myers Squibb DNA Repair Drugs Major Product Offerings
7.3.4 Bristol Myers Squibb DNA Repair Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Bristol Myers Squibb Key News
7.4 British Columbia Cancer Agency
7.4.1 British Columbia Cancer Agency Corporate Summary
7.4.2 British Columbia Cancer Agency Business Overview
7.4.3 British Columbia Cancer Agency DNA Repair Drugs Major Product Offerings
7.4.4 British Columbia Cancer Agency DNA Repair Drugs Sales and Revenue in Global (2017-2022)
7.4.5 British Columbia Cancer Agency Key News
7.5 Cambridge University Hospitals NHS Foundation Trust
7.5.1 Cambridge University Hospitals NHS Foundation Trust Corporate Summary
7.5.2 Cambridge University Hospitals NHS Foundation Trust Business Overview
7.5.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Major Product Offerings
7.5.4 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Cambridge University Hospitals NHS Foundation Trust Key News
7.6 Genentech
7.6.1 Genentech Corporate Summary
7.6.2 Genentech Business Overview
7.6.3 Genentech DNA Repair Drugs Major Product Offerings
7.6.4 Genentech DNA Repair Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Genentech Key News
7.7 Georgetown University
7.7.1 Georgetown University Corporate Summary
7.7.2 Georgetown University Business Overview
7.7.3 Georgetown University DNA Repair Drugs Major Product Offerings
7.7.4 Georgetown University DNA Repair Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Georgetown University Key News
7.8 German Breast Group
7.8.1 German Breast Group Corporate Summary
7.8.2 German Breast Group Business Overview
7.8.3 German Breast Group DNA Repair Drugs Major Product Offerings
7.8.4 German Breast Group DNA Repair Drugs Sales and Revenue in Global (2017-2022)
7.8.5 German Breast Group Key News
7.9 GlaxoSmithKline
7.9.1 GlaxoSmithKline Corporate Summary
7.9.2 GlaxoSmithKline Business Overview
7.9.3 GlaxoSmithKline DNA Repair Drugs Major Product Offerings
7.9.4 GlaxoSmithKline DNA Repair Drugs Sales and Revenue in Global (2017-2022)
7.9.5 GlaxoSmithKline Key News
7.10 Jiangsu Hengrui Medicine
7.10.1 Jiangsu Hengrui Medicine Corporate Summary
7.10.2 Jiangsu Hengrui Medicine Business Overview
7.10.3 Jiangsu Hengrui Medicine DNA Repair Drugs Major Product Offerings
7.10.4 Jiangsu Hengrui Medicine DNA Repair Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Jiangsu Hengrui Medicine Key News
7.11 Johnson & Johnson
7.11.1 Johnson & Johnson Corporate Summary
7.11.2 Johnson & Johnson DNA Repair Drugs Business Overview
7.11.3 Johnson & Johnson DNA Repair Drugs Major Product Offerings
7.11.4 Johnson & Johnson DNA Repair Drugs Sales and Revenue in Global (2017-2022)
7.11.5 Johnson & Johnson Key News
7.12 Jonsson Comprehensive Cancer Center
7.12.1 Jonsson Comprehensive Cancer Center Corporate Summary
7.12.2 Jonsson Comprehensive Cancer Center DNA Repair Drugs Business Overview
7.12.3 Jonsson Comprehensive Cancer Center DNA Repair Drugs Major Product Offerings
7.12.4 Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales and Revenue in Global (2017-2022)
7.12.5 Jonsson Comprehensive Cancer Center Key News
7.13 Karyopharm Therapeutics
7.13.1 Karyopharm Therapeutics Corporate Summary
7.13.2 Karyopharm Therapeutics DNA Repair Drugs Business Overview
7.13.3 Karyopharm Therapeutics DNA Repair Drugs Major Product Offerings
7.13.4 Karyopharm Therapeutics DNA Repair Drugs Sales and Revenue in Global (2017-2022)
7.13.5 Karyopharm Therapeutics Key News
7.14 KuDOS Pharmaceuticals
7.14.1 KuDOS Pharmaceuticals Corporate Summary
7.14.2 KuDOS Pharmaceuticals Business Overview
7.14.3 KuDOS Pharmaceuticals DNA Repair Drugs Major Product Offerings
7.14.4 KuDOS Pharmaceuticals DNA Repair Drugs Sales and Revenue in Global (2017-2022)
7.14.5 KuDOS Pharmaceuticals Key News
7.15 National Health Service
7.15.1 National Health Service Corporate Summary
7.15.2 National Health Service Business Overview
7.15.3 National Health Service DNA Repair Drugs Major Product Offerings
7.15.4 National Health Service DNA Repair Drugs Sales and Revenue in Global (2017-2022)
7.15.5 National Health Service Key News
7.16 National Institutes of Health
7.16.1 National Institutes of Health Corporate Summary
7.16.2 National Institutes of Health Business Overview
7.16.3 National Institutes of Health DNA Repair Drugs Major Product Offerings
7.16.4 National Institutes of Health DNA Repair Drugs Sales and Revenue in Global (2017-2022)
7.16.5 National Institutes of Health Key News
7.17 Tesaro
7.17.1 Tesaro Corporate Summary
7.17.2 Tesaro Business Overview
7.17.3 Tesaro DNA Repair Drugs Major Product Offerings
7.17.4 Tesaro DNA Repair Drugs Sales and Revenue in Global (2017-2022)
7.17.5 Tesaro Key News
8 Global DNA Repair Drugs Production Capacity, Analysis
8.1 Global DNA Repair Drugs Production Capacity, 2017-2028
8.2 DNA Repair Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global DNA Repair Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 DNA Repair Drugs Supply Chain Analysis
10.1 DNA Repair Drugs Industry Value Chain
10.2 DNA Repair Drugs Upstream Market
10.3 DNA Repair Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 DNA Repair Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of DNA Repair Drugs in Global Market
Table 2. Top DNA Repair Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global DNA Repair Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global DNA Repair Drugs Revenue Share by Companies, 2017-2022
Table 5. Global DNA Repair Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global DNA Repair Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers DNA Repair Drugs Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers DNA Repair Drugs Product Type
Table 9. List of Global Tier 1 DNA Repair Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 DNA Repair Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global DNA Repair Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global DNA Repair Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global DNA Repair Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global DNA Repair Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global DNA Repair Drugs Sales (K Units), 2023-2028
Table 16. By Application - Global DNA Repair Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global DNA Repair Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global DNA Repair Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global DNA Repair Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global DNA Repair Drugs Sales (K Units), 2023-2028
Table 21. By Region - Global DNA Repair Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global DNA Repair Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global DNA Repair Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global DNA Repair Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global DNA Repair Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America DNA Repair Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America DNA Repair Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America DNA Repair Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America DNA Repair Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe DNA Repair Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe DNA Repair Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe DNA Repair Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe DNA Repair Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia DNA Repair Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia DNA Repair Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia DNA Repair Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia DNA Repair Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America DNA Repair Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America DNA Repair Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America DNA Repair Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America DNA Repair Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa DNA Repair Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa DNA Repair Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa DNA Repair Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa DNA Repair Drugs Sales, (K Units), 2023-2028
Table 46. 4SC AG Corporate Summary
Table 47. 4SC AG DNA Repair Drugs Product Offerings
Table 48. 4SC AG DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. ARCAGY/ GINECO GROUP Corporate Summary
Table 50. ARCAGY/ GINECO GROUP DNA Repair Drugs Product Offerings
Table 51. ARCAGY/ GINECO GROUP DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Bristol Myers Squibb Corporate Summary
Table 53. Bristol Myers Squibb DNA Repair Drugs Product Offerings
Table 54. Bristol Myers Squibb DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. British Columbia Cancer Agency Corporate Summary
Table 56. British Columbia Cancer Agency DNA Repair Drugs Product Offerings
Table 57. British Columbia Cancer Agency DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Cambridge University Hospitals NHS Foundation Trust Corporate Summary
Table 59. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product Offerings
Table 60. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Genentech Corporate Summary
Table 62. Genentech DNA Repair Drugs Product Offerings
Table 63. Genentech DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Georgetown University Corporate Summary
Table 65. Georgetown University DNA Repair Drugs Product Offerings
Table 66. Georgetown University DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. German Breast Group Corporate Summary
Table 68. German Breast Group DNA Repair Drugs Product Offerings
Table 69. German Breast Group DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. GlaxoSmithKline Corporate Summary
Table 71. GlaxoSmithKline DNA Repair Drugs Product Offerings
Table 72. GlaxoSmithKline DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Jiangsu Hengrui Medicine Corporate Summary
Table 74. Jiangsu Hengrui Medicine DNA Repair Drugs Product Offerings
Table 75. Jiangsu Hengrui Medicine DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Johnson & Johnson Corporate Summary
Table 77. Johnson & Johnson DNA Repair Drugs Product Offerings
Table 78. Johnson & Johnson DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Jonsson Comprehensive Cancer Center Corporate Summary
Table 80. Jonsson Comprehensive Cancer Center DNA Repair Drugs Product Offerings
Table 81. Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Karyopharm Therapeutics Corporate Summary
Table 83. Karyopharm Therapeutics DNA Repair Drugs Product Offerings
Table 84. Karyopharm Therapeutics DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 85. KuDOS Pharmaceuticals Corporate Summary
Table 86. KuDOS Pharmaceuticals DNA Repair Drugs Product Offerings
Table 87. KuDOS Pharmaceuticals DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 88. National Health Service Corporate Summary
Table 89. National Health Service DNA Repair Drugs Product Offerings
Table 90. National Health Service DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 91. National Institutes of Health Corporate Summary
Table 92. National Institutes of Health DNA Repair Drugs Product Offerings
Table 93. National Institutes of Health DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 94. Tesaro Corporate Summary
Table 95. Tesaro DNA Repair Drugs Product Offerings
Table 96. Tesaro DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 97. DNA Repair Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 98. Global DNA Repair Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 99. Global DNA Repair Drugs Production by Region, 2017-2022 (K Units)
Table 100. Global DNA Repair Drugs Production by Region, 2023-2028 (K Units)
Table 101. DNA Repair Drugs Market Opportunities & Trends in Global Market
Table 102. DNA Repair Drugs Market Drivers in Global Market
Table 103. DNA Repair Drugs Market Restraints in Global Market
Table 104. DNA Repair Drugs Raw Materials
Table 105. DNA Repair Drugs Raw Materials Suppliers in Global Market
Table 106. Typical DNA Repair Drugs Downstream
Table 107. DNA Repair Drugs Downstream Clients in Global Market
Table 108. DNA Repair Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. DNA Repair Drugs Segment by Type
Figure 2. DNA Repair Drugs Segment by Application
Figure 3. Global DNA Repair Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global DNA Repair Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global DNA Repair Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. DNA Repair Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by DNA Repair Drugs Revenue in 2021
Figure 9. By Type - Global DNA Repair Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global DNA Repair Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global DNA Repair Drugs Price (USD/Unit), 2017-2028
Figure 12. By Application - Global DNA Repair Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global DNA Repair Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global DNA Repair Drugs Price (USD/Unit), 2017-2028
Figure 15. By Region - Global DNA Repair Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global DNA Repair Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America DNA Repair Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America DNA Repair Drugs Sales Market Share, 2017-2028
Figure 19. US DNA Repair Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada DNA Repair Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico DNA Repair Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe DNA Repair Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe DNA Repair Drugs Sales Market Share, 2017-2028
Figure 24. Germany DNA Repair Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France DNA Repair Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. DNA Repair Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy DNA Repair Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia DNA Repair Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries DNA Repair Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux DNA Repair Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia DNA Repair Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia DNA Repair Drugs Sales Market Share, 2017-2028
Figure 33. China DNA Repair Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan DNA Repair Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea DNA Repair Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia DNA Repair Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India DNA Repair Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America DNA Repair Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America DNA Repair Drugs Sales Market Share, 2017-2028
Figure 40. Brazil DNA Repair Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina DNA Repair Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa DNA Repair Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa DNA Repair Drugs Sales Market Share, 2017-2028
Figure 44. Turkey DNA Repair Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel DNA Repair Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia DNA Repair Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE DNA Repair Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global DNA Repair Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production DNA Repair Drugs by Region, 2021 VS 2028
Figure 50. DNA Repair Drugs Industry Value Chain
Figure 51. Marketing Channels
Global 5-Fluorouracil Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 76
The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030.
North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
Global Carboplatin Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 79
The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
Global Neutropenia Drugs Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 96
The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
Global Small Molecule Cancer Drug Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
Global Capecitabine Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 80
Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
Global Oxaliplatin Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 104
Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely.
In this report, only The finished drug is covered, exclude API.
The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
Global Cancer Treatment Drugs Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 158
According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period.
The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
Global Capecitabine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 93
According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period.
The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
Global Methotrexate Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 95
According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period.
The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
